-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

331.P1.24 331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-Related Thrombotic/Vascular Disorders: Clinical and Epidemiological: Poster I

Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Ayotola Fatola, MD1, Marshall Mazepa, MD2, Michael D Evans, MS3*, Jenna Brown, B.A.4* and Shruti Chaturvedi, MBBS4

1Johns Hopkins University School of Medicine, Baltimore, MD
2Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3University of Minnesota, Minneapolis, MN
4Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Aaron Boothby, MD1, Michael D Evans, MS2*, Shangbin Yang, PhD3*, Senthil Sukumar, MD, MSc4, James G Scott, Ph.D5*, Deirdra Terrell, PhD6, Spero Cataland, MD7 and Marshall Mazepa, MD8

1Hematology-Oncology Fellowship Program, University of Washington, Saint Paul, MN
2University of Minnesota, Minneapolis, MN
3Ohio State University, Columbus, OH
4Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX
5Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City
6University of Oklahoma, Oklahoma City, OK
7Division of Hematology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH
8Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Jenna Brown, B.A.1*, Shruti Chaturvedi, MBBS1 and Marshall Mazepa, MD2

1Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
2Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Munjal Patel1*, Olivier Barriere2*, Paul Diderichsen2*, Huijuan Xu1*, Andy Zhu1*, Jean François Marier2*, Björn Mellgård1, Wenping Wang1* and Indranil Bhattacharya1*

1Takeda Development Center Americas, Inc., Cambridge, MA
2Certara Strategic Consulting, Princeton, NJ

PAUL Coppo1*, Marie Scully, MD2, Johanna A. Kremer Hovinga, MD3, Maria Jose Aragon4*, Parth Patwari, MD, PhD5*, Linda T. Wang5*, Bjorn Mellgard5, Olulade Ayodele5* and Ragy Saad5*

1APHP - Hôpital St Antoine, Paris, France
2University College London, London, ENG, United Kingdom
3Department of Hematology and Central Hematology Laboratory, Bern University Hospital, Bern, Switzerland
4HCD Economics, Daresbury, United Kingdom
5Takeda Development Center Americas, Inc., Cambridge, MA

Rushad Patell, MBBS1, Dana E. Angelini, MD2, Stacy R Ellsworth3*, Paul Lewis4*, James C Lee5*, Edith A. Nutescu5*, Alpesh Amin6*, Daniel M Witt, PharmD7*, Marisol Betensky, MD8, Neil Goldenberg, MD, PhD8, Peter Kouides9, Doaa Attia, MD, MBBS10*, Lyla Mourany10*, Leslie Lake11*, Rachel P. Rosovsky, MD12, Alok A. Khorana, MD13 and Scott Kaatz, DO, MSc14*

1Division of Medical Oncology and Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
3Henry Ford Health System, Detroit
4Baycare Health System, Clearwater, FL
5University of Illinois, Chicago, IL
6University of California, Irvine, CA
7University of Utah, Salt Lake City, UT
8Johns Hopkins All Children's Hospital, Saint Petersburg, FL
9University of Rochester, Rochester, NY
10Cleveland Clinic Foundation, Cleveland, OH
11National Blood Clot Alliance, Philadelphia, PA
12Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
13CLEVELAND CLINIC - US, Cleveland, OH
14Division of Hospital Medicine, Henry Ford Health, Detroit, MI

Saisree Reddy Adla Jala, MD1*, Sailaja Sanikommu, MBBS2*, Suma Sri Chennapragada, MD3, Balkiranjit Kaur Dhillon, MBBS4*, Shruti Aggarwal, MBBS5*, Saloni Savani, MD6*, Salini Ajitha, MBBS7*, Mehndi Dandwani, MBBS8, Vaishnavi Singh, MD9*, Arcita Hanjani Pramudita, MD10*, Shriya Goyal, MD11*, Sindhu Thevuthasan, MD12*, Hemamalini Sakthivel, MD13*, Kamleshun Ramphul, MD14* and Shivani Sharma, MBBS15

1Centinela Hospital Medical Center Inglewood, CA 90301, Inglewood, CA
2SJMedSpace, Chennai, India
3LSUHSC-S/Feist-Weiller Cancer Center, Shreveport, LA
4Independent Researcher, Brampton, Canada
5Independent Researcher, Bhatinda, India
6Wills Knighton Health System, Shreveport, LA
7TD Medical college, Kerala, India, Kerala, India
8University of Iowa Hospitals and Clinics, Iowa, IA
9Willis-Knighton Health System, Shreveport, LA
10Harvard Medical School/Dana-Farber Cancer Institute, Boston, MA
11LSUHS SHREVEPORT, Shreveport, LA
12LSU Health Shreveport, Shreveport, LA
13One Brooklyn Health System/Interfaith Medical Center Program, Brooklyn, NY, USA., New York
14Independent Researcher, Triolet, Mauritius
15Assistant Professor Clinical of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA

Shaikha Alqahtani, MD1, Faryal Munir, MD, MBBS2, Lucas Ramsey3*, Olga Starostina3*, David McCall, MD4* and Nidra Rodriguez, MD2,5*

1Division of Pediatrics, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
2Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
3Enterprise Data Engineering and Analytics (EDEA), University of Texas MD Anderson Cancer Center, HOUSTON
4Division of Pediatrics, MD Anderson, Houston, TX
5The University of Texas Health Science Center Houston, Houston, TX

Karl Roberts, MS, MA, BA*, Zi Yan*, Shouping Zhang*, Emmanuel Olivier, PhD*, Khulan Batbayar, PhD* and Eric E Bouhassira, PhD

Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY

*signifies non-member of ASH